Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thijo J N Hiltermann

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|November 17, 2011
[New 'targeted therapy' for lung cancer]Harry J M Groen, Thijo J N Hiltermann, Ed Schuuring, et al.
Annals of Translational Medicine|March 28, 2015
The value of proteomics in lung cancerAnthonie J van der Wekken, Thijo J N Hiltermann, Harry J M Groen
BMJ Case Reports|June 8, 2012
A malignant retroperitoneal mass--a rare presentation of recurrent thymomaWouter H van Geffen, Johanna Sietsma, Pieter M M Roelofs, et al.
European Journal of Cancer Care|August 24, 2018
Correspondence between primary and secondary care about patients with cancer: A qualitative mixed-methods analysisMariken E Stegmann, Jiska M Meijer, Janine Nuver, et al.
EJNMMI Research|April 20, 2016
An exploratory study of volumetric analysis for assessing tumor response with (18)F-FAZA PET/CT in patients with advanced non-small-cell lung cancer (NSCLC)Gerald S M A Kerner, Vikram R Bollineni, Thijo J N Hiltermann, et al.
Journal of Palliative Medicine|June 26, 2020
Adherence and Concordance between Serious Illness Care Planning Conversations and Oncology Clinician Documentation among Patients with Advanced CancerOlaf P Geerse, Daniela J Lamas, Rachelle E Bernacki, et al.
Journal of Palliative Medicine|February 7, 2019
A Qualitative Study of Serious Illness Conversations in Patients with Advanced CancerOlaf P Geerse, Daniela J Lamas, Justin J Sanders, et al.
Plos One|August 8, 2013
Common and rare EGFR and KRAS mutations in a Dutch non-small-cell lung cancer population and their clinical outcomeGerald S M A Kerner, Ed Schuuring, Johanna Sietsma, et al.
Radiation Oncology (London, England)|September 2, 2014
Concurrent gemcitabine and 3D radiotherapy in patients with stage III unresectable non-small cell lung cancerGerald S M A Kerner, Leon F A van Dullemen, Erwin M Wiegman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 14, 2015
An instrument dedicated for modelling of pulmonary radiotherapyAnne G H Niezink, Nienke J Dollekamp, Harriet J Elzinga, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nederlands Tijdschrift Voor Geneeskunde|November 17, 2011
[New 'targeted therapy' for lung cancer]Harry J M Groen, Thijo J N Hiltermann, Ed Schuuring, et al.
Annals of Translational Medicine|March 28, 2015
The value of proteomics in lung cancerAnthonie J van der Wekken, Thijo J N Hiltermann, Harry J M Groen
BMJ Case Reports|June 8, 2012
A malignant retroperitoneal mass--a rare presentation of recurrent thymomaWouter H van Geffen, Johanna Sietsma, Pieter M M Roelofs, et al.
European Journal of Cancer Care|August 24, 2018
Correspondence between primary and secondary care about patients with cancer: A qualitative mixed-methods analysisMariken E Stegmann, Jiska M Meijer, Janine Nuver, et al.
EJNMMI Research|April 20, 2016
An exploratory study of volumetric analysis for assessing tumor response with (18)F-FAZA PET/CT in patients with advanced non-small-cell lung cancer (NSCLC)Gerald S M A Kerner, Vikram R Bollineni, Thijo J N Hiltermann, et al.
Journal of Palliative Medicine|June 26, 2020
Adherence and Concordance between Serious Illness Care Planning Conversations and Oncology Clinician Documentation among Patients with Advanced CancerOlaf P Geerse, Daniela J Lamas, Rachelle E Bernacki, et al.
Journal of Palliative Medicine|February 7, 2019
A Qualitative Study of Serious Illness Conversations in Patients with Advanced CancerOlaf P Geerse, Daniela J Lamas, Justin J Sanders, et al.
Plos One|August 8, 2013
Common and rare EGFR and KRAS mutations in a Dutch non-small-cell lung cancer population and their clinical outcomeGerald S M A Kerner, Ed Schuuring, Johanna Sietsma, et al.
Radiation Oncology (London, England)|September 2, 2014
Concurrent gemcitabine and 3D radiotherapy in patients with stage III unresectable non-small cell lung cancerGerald S M A Kerner, Leon F A van Dullemen, Erwin M Wiegman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 14, 2015
An instrument dedicated for modelling of pulmonary radiotherapyAnne G H Niezink, Nienke J Dollekamp, Harriet J Elzinga, et al.
Pageof 1